Literature DB >> 25467622

Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study.

Elke R Fährmann1, Laura Adkins2, Cameron J Loader2, Hyoil Han3, Kevin M Rice4, James Denvir5, Henry K Driscoll6.   

Abstract

AIM: Recently, major attention has been paid to the role of hypoglycemia as a cardiovascular risk factor. While EURODIAB-investigators concluded that severe hypoglycemia is not a cardiovascular risk factor in type 1 diabetes, other investigators found the opposite. The primary purpose of this study was to investigate the role of severe hypoglycemia in atherosclerosis during the DCCT- and EDIC-years with special attention to overall glycemic levels. RESEARCH DESIGN AND METHODS: The effect of severe hypoglycemic rates on coronary artery calcification (CAC) was evaluated for the entire cohort (n = 1205) and glycemic stratified cohorts (HbA1C < 7.5% [58 mmol/mol], HbA1C ≥ 7.5%).
RESULTS: The association between CAC and mean DCCT-hypoglycemia rate was stronger than the association between CAC and mean EDIC-hypoglycemia rate. Although the DCCT-severe hypoglycemia rate without HbA1C-stratification was not significantly associated with a CAC-score ≥ 100 Agatston units (p = 0.093), the interaction between above glycemic ranges and DCCT-hypoglycemic rate was significant (p < 0.05). A sub-analysis of patients belonging to the lower glycemic range (HbA1C < 7.5%), adjusted for baseline age, gender, baseline diabetes duration, baseline neuropathy, baseline albumin excretion rate, systolic blood pressure, LDL-cholesterol, smoking status, body mass index and DCCT-A1C, indicated significant (p = 0.02) associations between DCCT-severe hypoglycemia rate and CAC-score ≥ 100. One unit increase in the natural logarithm transformed DCCT-severe hypoglycemia rate increased the risk of having a CAC ≥ 100 by 30%.
CONCLUSIONS: Our results suggest a cumulative effect of hypoglycemic events on cardiovascular risk. They provide a possible link between above mentioned contradictory reports. Our findings support the relevance of personalizing glycemic goals in diabetes management beyond HbA1C.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Coronary artery calcification; DCCT/EDIC-study; Severe hypoglycemia; Type 1 diabetes

Mesh:

Substances:

Year:  2014        PMID: 25467622      PMCID: PMC6843991          DOI: 10.1016/j.diabres.2014.10.007

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  44 in total

1.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Authors:  David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

2.  Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group.

Authors: 
Journal:  Diabetes       Date:  1997-02       Impact factor: 9.461

3.  Progression of coronary artery calcification in type 1 diabetes: the importance of glycemic control.

Authors:  Janet K Snell-Bergeon; John E Hokanson; Lisa Jensen; Todd MacKenzie; Gregory Kinney; Dana Dabelea; Robert H Eckel; James Ehrlich; Satish Garg; Marian Rewers
Journal:  Diabetes Care       Date:  2003-10       Impact factor: 19.112

Review 4.  Coronary artery calcium score prediction of all cause mortality and cardiovascular events in people with type 2 diabetes: systematic review and meta-analysis.

Authors:  Caroline K Kramer; Bernard Zinman; Jorge L Gross; Luis H Canani; Ticiana C Rodrigues; Mirela J Azevedo; Ravi Retnakaran
Journal:  BMJ       Date:  2013-03-25

5.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

6.  Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.

Authors: 
Journal:  JAMA       Date:  2003-10-22       Impact factor: 56.272

7.  Low prevalence of subclinical atherosclerosis in asymptomatic patients with type 1 diabetes in a European Mediterranean population.

Authors:  Eva Aguilera; Enric Serra-Planas; M Luisa Granada; Núria Alonso; Silvia Pellitero; Eduarda Pizarro; Jordi Lluís Reverter; Isabel Salinas; Berta Soldevila; Dídac Mauricio; Manel Puig-Domingo
Journal:  Diabetes Care       Date:  2013-10-17       Impact factor: 19.112

8.  Evidence linking hypoglycemic events to an increased risk of acute cardiovascular events in patients with type 2 diabetes.

Authors:  Stephen S Johnston; Christopher Conner; Mark Aagren; David M Smith; Jonathan Bouchard; Jason Brett
Journal:  Diabetes Care       Date:  2011-03-18       Impact factor: 19.112

9.  HbA1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging Study.

Authors:  Kasia J Lipska; E Margaret Warton; Elbert S Huang; Howard H Moffet; Silvio E Inzucchi; Harlan M Krumholz; Andrew J Karter
Journal:  Diabetes Care       Date:  2013-07-30       Impact factor: 19.112

10.  Severe hypoglycemia and cardiovascular disease incidence in type 1 diabetes: the EURODIAB Prospective Complications Study.

Authors:  Gabriella Gruden; Federica Barutta; Nish Chaturvedi; Casper Schalkwijk; Coen D Stehouwer; Daniel R Witte; John H Fuller; Paolo Cavallo Perin; Graziella Bruno
Journal:  Diabetes Care       Date:  2012-05-14       Impact factor: 19.112

View more
  13 in total

Review 1.  Interdisciplinary approach to compensation of hypoglycemia in diabetic patients with chronic heart failure.

Authors:  Yana Anfinogenova; Elena V Grakova; Maria Shvedova; Kristina V Kopieva; Alexander T Teplyakov; Sergey V Popov
Journal:  Heart Fail Rev       Date:  2018-05       Impact factor: 4.214

Review 2.  The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it.

Authors:  Alicia Jenkins; Andrzej Januszewski; David O'Neal
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-02-13

3.  A Link Between Hypoglycemia and Progression of Atherosclerosis in the Veterans Affairs Diabetes Trial (VADT).

Authors:  Aramesh Saremi; Gideon D Bahn; Peter D Reaven
Journal:  Diabetes Care       Date:  2016-01-19       Impact factor: 19.112

Review 4.  Glucose-Lowering Therapy beyond Insulin in Type 1 Diabetes: A Narrative Review on Existing Evidence from Randomized Controlled Trials and Clinical Perspective.

Authors:  Felix Aberer; Thomas R Pieber; Max L Eckstein; Harald Sourij; Othmar Moser
Journal:  Pharmaceutics       Date:  2022-05-31       Impact factor: 6.525

Review 5.  Metabolic and Biochemical Stressors in Diabetic Cardiomyopathy.

Authors:  Vasundhara Kain; Ganesh V Halade
Journal:  Front Cardiovasc Med       Date:  2017-05-31

6.  Monoconjugation of Human Amylin with Methylpolyethyleneglycol.

Authors:  Tháyna Sisnande; Luiz Henrique Guerreiro; Raquel R Braga; Luana Jotha-Mattos; Luiza C S Erthal; Priscilla Tinoco; Bruno M Ferreira; Luís Maurício T R Lima
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

7.  Severe Hypoglycemia and Cardiovascular or All-Cause Mortality in Patients with Type 2 Diabetes.

Authors:  Seon Ah Cha; Jae Seung Yun; Tae Seok Lim; Seawon Hwang; Eun Jung Yim; Ki Ho Song; Ki Dong Yoo; Yong Moon Park; Yu Bae Ahn; Seung Hyun Ko
Journal:  Diabetes Metab J       Date:  2016-04-21       Impact factor: 5.376

Review 8.  Devices for continuous monitoring of glucose: update in technology.

Authors:  Ana María Gómez; Diana Cristina Henao Carrillo; Oscar Mauricio Muñoz Velandia
Journal:  Med Devices (Auckl)       Date:  2017-09-12

9.  Relationship of Hyperglycaemia, Hypoglycaemia, and Glucose Variability to Atherosclerotic Disease in Type 2 Diabetes.

Authors:  Caroline Jane Magri; Dillon Mintoff; Liberato Camilleri; Robert G Xuereb; Joseph Galea; Stephen Fava
Journal:  J Diabetes Res       Date:  2018-07-22       Impact factor: 4.011

10.  Understanding the impact of hypoglycemia on the cardiovascular system.

Authors:  Ian Charles Davis; Ida Ahmadizadeh; Jacqueline Randell; Lisa Younk; Stephen N Davis
Journal:  Expert Rev Endocrinol Metab       Date:  2017-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.